<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>ARDS: Comprehensive Critical Care Review</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background-color: #f0f7fd;
            color: #333;
            line-height: 1.6;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        
        header {
            background: linear-gradient(135deg, #1a6db1 0%, #0a4a82 100%);
            color: white;
            padding: 2rem;
            border-radius: 10px;
            margin-bottom: 2rem;
            box-shadow: 0 4px 15px rgba(0, 0, 0, 0.1);
        }
        
        header h1 {
            font-size: 2.5rem;
            margin-bottom: 0.5rem;
        }
        
        header p {
            font-size: 1.1rem;
            opacity: 0.9;
        }
        
        .last-update {
            font-style: italic;
            margin-top: 1rem;
            font-size: 0.9rem;
        }
        
        .content-wrapper {
            display: grid;
            grid-template-columns: 1fr 350px;
            gap: 2rem;
        }
        
        .main-content {
            background: white;
            border-radius: 10px;
            padding: 2rem;
            box-shadow: 0 4px 15px rgba(0, 0, 0, 0.05);
        }
        
        .sidebar {
            background: white;
            border-radius: 10px;
            padding: 1.5rem;
            box-shadow: 0 4px 15px rgba(0, 0, 0, 0.05);
        }
        
        h2 {
            color: #0a4a82;
            margin: 2rem 0 1rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid #e3f2fd;
        }
        
        h2:first-child {
            margin-top: 0;
        }
        
        h3 {
            color: #1a6db1;
            margin: 1.5rem 0 0.8rem;
        }
        
        p {
            margin-bottom: 1rem;
        }
        
        .definition-box {
            background: #e3f2fd;
            border-left: 5px solid #1a6db1;
            padding: 1.5rem;
            border-radius: 5px;
            margin: 1.5rem 0;
        }
        
        .reference {
            background: #f5f5f5;
            padding: 1rem;
            border-radius: 5px;
            margin: 1rem 0;
            font-size: 0.9rem;
        }
        
        .reference h4 {
            margin-bottom: 0.3rem;
            color: #1a6db1;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
        }
        
        th, td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid #ddd;
        }
        
        th {
            background-color: #e3f2fd;
            color: #0a4a82;
        }
        
        tr:hover {
            background-color: #f9f9f9;
        }
        
        .highlight {
            background-color: #fff8e1;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-weight: 600;
        }
        
        .key-points {
            background: #e8f5e9;
            padding: 1.5rem;
            border-radius: 8px;
            margin: 1.5rem 0;
        }
        
        .key-points h3 {
            color: #2e7d32;
            margin-top: 0;
        }
        
        .key-points ul {
            margin-left: 1.5rem;
        }
        
        .key-points li {
            margin-bottom: 0.5rem;
        }
        
        .section-nav {
            position: sticky;
            top: 20px;
        }
        
        .section-nav h3 {
            margin-top: 0;
        }
        
        .section-nav ul {
            list-style: none;
        }
        
        .section-nav li {
            margin-bottom: 0.5rem;
        }
        
        .section-nav a {
            color: #1a6db1;
            text-decoration: none;
            display: block;
            padding: 8px 12px;
            border-radius: 5px;
            transition: background 0.3s;
        }
        
        .section-nav a:hover {
            background: #e3f2fd;
        }
        
        .guideline-box {
            background: #ffecb3;
            padding: 1rem;
            border-radius: 8px;
            margin: 1rem 0;
            border-left: 5px solid #ffc107;
        }
        
        .guideline-box h4 {
            color: #7d6608;
            margin-bottom: 0.5rem;
        }
        
        .footer {
            text-align: center;
            margin-top: 3rem;
            padding: 2rem;
            color: #666;
            font-size: 0.9rem;
        }
        
        @media (max-width: 900px) {
            .content-wrapper {
                grid-template-columns: 1fr;
            }
            
            .section-nav {
                position: relative;
                top: 0;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1><i class="fas fa-lungs-virus"></i> Acute Respiratory Distress Syndrome (ARDS)</h1>
            <p>A Comprehensive Evidence-Based Review for Critical Care Professionals</p>
            <p class="last-update">Last updated: October 2023</p>
        </header>
        
        <div class="content-wrapper">
            <div class="main-content">
                <section id="definition">
                    <h2><i class="fas fa-book-medical"></i> Definition and Evolution</h2>
                    <p>Acute Respiratory Distress Syndrome (ARDS) is a life-threatening form of respiratory failure characterized by diffuse alveolar damage and increased pulmonary vascular permeability.</p>
                    
                    <div class="definition-box">
                        <h3>Berlin Definition (2012) - Current Diagnostic Criteria</h3>
                        <ul>
                            <li><strong>Timing:</strong> Within 1 week of a known clinical insult or new/worsening respiratory symptoms</li>
                            <li><strong>Chest imaging:</strong> Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules</li>
                            <li><strong>Origin of edema:</strong> Respiratory failure not fully explained by cardiac failure or fluid overload</li>
                            <li><strong>Oxygenation impairment (with PEEP ≥5 cm H₂O):</strong>
                                <ul>
                                    <li><strong>Mild:</strong> 200 mmHg < PaO₂/FiO₂ ≤ 300 mmHg</li>
                                    <li><strong>Moderate:</strong> 100 mmHg < PaO₂/FiO₂ ≤ 200 mmHg</li>
                                    <li><strong>Severe:</strong> PaO₂/FiO₂ ≤ 100 mmHg</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                    
                    <p>The Berlin Definition refined the previous American-European Consensus Conference (AECC) criteria, improving reliability and validity for predicting outcomes.</p>
                    
                    <div class="reference">
                        <h4>Key Reference:</h4>
                        <p>ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-33.</p>
                    </div>
                </section>
                
                <section id="epidemiology">
                    <h2><i class="fas fa-chart-line"></i> Epidemiology</h2>
                    <p>ARDS represents a significant burden in critical care medicine with an estimated incidence of 10-86 cases per 100,000 person-years globally.</p>
                    
                    <table>
                        <tr>
                            <th>Severity</th>
                            <th>Incidence (%)</th>
                            <th>Mortality (%)</th>
                        </tr>
                        <tr>
                            <td>Mild</td>
                            <td>30-50%</td>
                            <td>27%</td>
                        </tr>
                        <tr>
                            <td>Moderate</td>
                            <td>30-40%</td>
                            <td>32%</td>
                        </tr>
                        <tr>
                            <td>Severe</td>
                            <td>10-20%</td>
                            <td>45%</td>
                        </tr>
                    </table>
                    
                    <p>The COVID-19 pandemic dramatically increased the global incidence of ARDS, with approximately 20-40% of hospitalized COVID-19 patients developing ARDS.</p>
                </section>
                
                <section id="pathophysiology">
                    <h2><i class="fas fa-lungs"></i> Pathophysiology</h2>
                    <p>ARDS is characterized by diffuse alveolar damage resulting from an uncontrolled inflammatory response to direct or indirect lung injury.</p>
                    
                    <h3>Key Pathophysiological Mechanisms:</h3>
                    <ul>
                        <li><strong>Alveolar-capillary barrier disruption:</strong> Increased permeability leads to protein-rich pulmonary edema</li>
                        <li><strong>Surfactant dysfunction:</strong> Loss of surface tension-reducing properties promotes alveolar collapse</li>
                        <li><strong>Inflammatory mediator release:</strong> Neutrophil infiltration and cytokine release cause tissue damage</li>
                        <li><strong>Coagulation abnormalities:</strong> Intra-alveolar fibrin deposition and microvascular thrombosis</li>
                        <li><strong>Ventilator-induced lung injury (VILI):</strong> Mechanical ventilation can exacerbate lung injury through volutrauma, barotrauma, and atelectrauma</li>
                    </ul>
                    
                    <div class="key-points">
                        <h3><i class="fas fa-lightbulb"></i> Clinical Pearl: The "Baby Lung" Concept</h3>
                        <p>The aerated lung in ARDS is not a small, healthy lung but rather a small, normally aerated compartment within a diseased, non-aerated lung. This explains why even low tidal volumes can cause volutrauma if not adjusted for the reduced aerated volume.</p>
                    </div>
                </section>
                
                <section id="management">
                    <h2><i class="fas fa-stethoscope"></i> Management</h2>
                    <p>The management of ARDS requires a multifaceted approach focusing on treating the underlying cause, supportive care, and lung-protective strategies.</p>
                    
                    <h3>Ventilatory Management</h3>
                    
                    <div class="guideline-box">
                        <h4><i class="fas fa-clipboard-list"></i> SCCM/ESICM 2023 Guideline Recommendations:</h4>
                        <ul>
                            <li>Use <span class="highlight">low tidal volume ventilation (4-8 mL/kg predicted body weight)</span> and target plateau pressures <30 cm H₂O (strong recommendation)</li>
                            <li>Use <span class="highlight">prone positioning for >12 hours daily</span> in severe ARDS (strong recommendation)</li>
                            <li>Use a <span class="highlight">conservative fluid strategy</span> after initial resuscitation (strong recommendation)</li>
                            <li>Use <span class="highlight">neuromuscular blocking agents</span> for 48 hours in early severe ARDS (weak recommendation)</li>
                            <li>Consider <span class="highlight">corticosteroids</span> in moderate-to-severe ARDS (weak recommendation)</li>
                        </ul>
                    </div>
                    
                    <h4>Lung-Protective Ventilation Strategy:</h4>
                    <table>
                        <tr>
                            <th>Parameter</th>
                            <th>Recommendation</th>
                            <th>Rationale</th>
                        </tr>
                        <tr>
                            <td>Tidal Volume</td>
                            <td>4-8 mL/kg PBW</td>
                            <td>Reduces volutrauma and mortality</td>
                        </tr>
                        <tr>
                            <td>Plateau Pressure</td>
                            <td><30 cm H₂O</td>
                            <td>Reduces barotrauma</td>
                        </tr>
                        <tr>
                            <td>PEEP</td>
                            <td>Individualized titration</td>
                            <td>Prevents atelectrauma while avoiding overdistension</td>
                        </tr>
                        <tr>
                            <td>Driving Pressure</td>
                            <td><14 cm H₂O</td>
                            <td>Strong predictor of survival</td>
                        </tr>
                        <tr>
                            <td>FiO₂</td>
                            <td>Minimize to <60% when possible</td>
                            <td>Reduces oxygen toxicity</td>
                        </tr>
                    </table>
                    
                    <div class="reference">
                        <h4>Key Reference:</h4>
                        <p>Griffiths MJD, et al. Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res 2023;10:e001461.</p>
                    </div>
                    
                    <h3>Rescue Therapies for Refractory Hypoxemia</h3>
                    <ul>
                        <li><strong>Neuromuscular blockade:</strong> Early, short-term use in severe ARDS improves oxygenation and reduces VILI</li>
                        <li><strong>Prone positioning:</strong> Improves ventilation-perfusion matching and reduces mortality in severe ARDS</li>
                        <li><strong>ECMO (Extracorporeal Membrane Oxygenation):</strong> Consider in selected patients with refractory hypoxemia despite optimal management</li>
                        <li><strong>Inhaled pulmonary vasodilators:</strong> May improve oxygenation but no mortality benefit demonstrated</li>
                    </ul>
                </section>
                
                <section id="prognosis">
                    <h2><i class="fas fa-procedures"></i> Prognosis and Outcomes</h2>
                    <p>Despite advances in management, ARDS continues to have significant mortality and long-term morbidity.</p>
                    
                    <h3>Mortality Predictors:</h3>
                    <ul>
                        <li>Older age</li>
                        <li>Non-pulmonary organ dysfunction</li>
                        <li>Severity of hypoxemia (PaO₂/FiO₂ ratio)</li>
                        <li>Underlying etiology (worse with direct lung injury)</li>
                        <li>Comorbidities (especially chronic liver disease)</li>
                    </ul>
                    
                    <h3>Long-Term Sequelae (Post-Intensive Care Syndrome):</h3>
                    <ul>
                        <li><strong>Physical:</strong> Muscle weakness, functional impairment, reduced exercise tolerance</li>
                        <li><strong>Pulmonary:</strong> Restrictive lung disease, reduced diffusion capacity</li>
                        <li><strong>Cognitive:</strong> Impaired memory, executive function, and attention</li>
                        <li><strong>Psychological:</strong> Depression, anxiety, and post-traumatic stress disorder</li>
                    </ul>
                    
                    <p>Follow-up care should include multidisciplinary rehabilitation addressing physical, cognitive, and psychological impairments.</p>
                </section>
            </div>
            
            <div class="sidebar">
                <div class="section-nav">
                    <h3><i class="fas fa-list"></i> Article Sections</h3>
                    <ul>
                        <li><a href="#definition"><i class="fas fa-chevron-right"></i> Definition and Evolution</a></li>
                        <li><a href="#epidemiology"><i class="fas fa-chevron-right"></i> Epidemiology</a></li>
                        <li><a href="#pathophysiology"><i class="fas fa-chevron-right"></i> Pathophysiology</a></li>
                        <li><a href="#management"><i class="fas fa-chevron-right"></i> Management</a></li>
                        <li><a href="#prognosis"><i class="fas fa-chevron-right"></i> Prognosis</a></li>
                    </ul>
                    
                    <h3><i class="fas fa-book-medical"></i> Key Guidelines</h3>
                    <ul>
                        <li>SCCM/ESICM 2023</li>
                        <li>ATS 2017</li>
                        <li>ERS 2017</li>
                    </ul>
                    
                    <h3><i class="fas fa-file-pdf"></i> Resources</h3>
                    <ul>
                        <li><a href="#"><i class="fas fa-download"></i> Download PDF Summary</a></li>
                        <li><a href="#"><i class="fas fa-external-link-alt"></i> ARDS Clinical Network</a></li>
                        <li><a href="#"><i class="fas fa-external-link-alt"></i> ESICM Guidelines</a></li>
                    </ul>
                    
                    <div class="key-points">
                        <h3><i class="fas fa-star"></i> Key Takeaways</h3>
                        <ul>
                            <li>Use low tidal volume ventilation (6 mL/kg PBW)</li>
                            <li>Prone positioning reduces mortality in severe ARDS</li>
                            <li>Conservative fluid strategy improves outcomes</li>
                            <li>Corticosteroids may be considered in moderate-severe cases</li>
                            <li>Multidisciplinary follow-up is essential for survivors</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        
        <div class="footer">
            <p>This information is intended for healthcare professionals only. Always consult current guidelines and apply clinical judgment.</p>
            <p>© 2023 Critical Care Reviews. All rights reserved.</p>
        </div>
    </div>

    <script>
        // Smooth scrolling for navigation links
        document.querySelectorAll('.section-nav a').forEach(anchor => {
            anchor.addEventListener('click', function(e) {
                e.preventDefault();
                
                const targetId = this.getAttribute('href');
                const targetElement = document.querySelector(targetId);
                
                window.scrollTo({
                    top: targetElement.offsetTop - 20,
                    behavior: 'smooth'
                });
            });
        });
        
        // Highlight current section in navigation
        window.addEventListener('scroll', function() {
            const sections = document.querySelectorAll('section');
            const navLinks = document.querySelectorAll('.section-nav a');
            
            let currentSection = '';
            
            sections.forEach(section => {
                const sectionTop = section.offsetTop;
                const sectionHeight = section.clientHeight;
                
                if (pageYOffset >= (sectionTop - 100)) {
                    currentSection = section.getAttribute('id');
                }
            });
            
            navLinks.forEach(link => {
                link.classList.remove('active');
                if (link.getAttribute('href').substring(1) === currentSection) {
                    link.classList.add('active');
                    link.style.background = '#e3f2fd';
                }
            });
        });
    </script>
</body>
</html>